Approximately 10 years after the establishment of the Maine Vaccine Board (MVB) in 2010, consulting firm BerryDunn conducted a third-party impact analysis to assess the efficacy of the MVB’s universal purchase program. Conducted over the most recent four-year operating period, the study reveals that the MVB, in partnership with the Maine Universal Childhood Immunization Program (MUCIP), saves insurance providers over $4 million annually. Moreover, the cost savings both exhibit a rising trend (totaling over $5 million over the last fiscal year studied), and accrue to the payers, which in turns lowers health insurance premiums for companies and individuals.

GO TO FULL ARTICLE

VACCINE HESITANCY

VACCINE FACTS